Ebola virus defective interfering particles and persistent infection

Virology

Volumn 262, Issue 1, 1999, Pages 114-128

  Calain, Philippe ^a   Monroe, Martha C ^a   Nichol, Stuart T ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

ANIMAL CELL; ARTICLE; DEFECTIVE VIRUS; DISEASE TRANSMISSION; EBOLA VIRUS; FILOVIRIDAE; NONHUMAN; PARAMYXOVIRUS; PERSISTENT INFECTION; PRIORITY JOURNAL; TISSUE CULTURE; ULTRAVIOLET IRRADIATION; VIRUS REPLICATION;

ANIMALIA; EBOLA VIRUS; FILOVIRIDAE; PARAMYXOVIRIDAE; PARAMYXOVIRINAE; RNA VIRUSES;

EID: 0033568373     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9915     Document Type: Article

References (62)

1. Ahmed R., Canning W. M., Kauffman R. S., Sharpe A. H., Hallum J. V., Fields B. N. Role of the host cell in persistent viral infection: Coevolution of L cells and reovoirus during persistent infection. Cell. 25:1981;325-332.
2. Bukreyev A. A., Volchkov V. E., Blinov V. M., Dryga S. A., Netesov S. V. The complete nucleotide sequence of the Popp (1967) strain of Marburg virus - A comparison with the Musoke (1980) strain. Arch. Virol. 140:1995;1589-1600.
3. Bwaka M. A., Bonnet M.-J., Calain P., Colebunders R., De Roo A., Guimard Y., Katwiki K. R., Kibadi K., Kipasa M. A., Kuvula K. J., Mapanda B. B., Massamba M., Mupapa K. D., Tamfun-Muyembe J.-J., Ndaberey E., Peters C. J., Rollin P. E., van den Enden E. Ebola hemorrhagic fever in Kikwit, Democratic Republic of Congo (former Zaire): Clinical observations. J. Infect. Dis. 179:1999;S1-S7.
4. Calain P., Curran J., Kolakofsky D., Roux L. Molecular cloning of natural paramyxovirus copy-back defective interfering RNAs and their expression from DNA. Virology. 191:1992;62-71.
5. Calain P., Roux L. Generation of measles virus defective interfering particles and their presence in a preparation of attenuated live-virus vaccine. J. Virol. 62:1988;2859-2866.
6. Calain P., Roux L. The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J. Virol. 67:1993;4822-4830.
7. Calain P., Roux L. Functional characterisation of the genomic and antigenomic promoters of Sendai virus. Virology. 212:1995;163-173.
8. Collins P. The molecular biology of human respiratory syncitial virus (RSV) of the genus Pneumovirus. Kingsbury D. W. The Paramyxoviruses. 1991;103-162 Plenum Press, New York.
9. Collins P. L., Hill M. G., Camargo E., Grosfeld H., Chanock R. M., Murphy B. R. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5′ proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. Proc. Natl. Acad. Sci. USA. 92:1995;11563-11567.
10. Dowell S. F., Mukunu R., Ksiazek T. G., Khan A. S., Rollin P. E., Peters C. J. Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. J. Infect. Dis. 179:1999;S87-S91.
11. Durbin A. P., Siew J. W., Murphy B. R., Collins P. L. Minimum protein requirements for transcription and RNA replication of a minigenome of human parainfluenza virus type 3 and evaluation of the rule of six. Virology. 234:1997;74-83.
12. Ellis D. S., Stamford S., Lloyd G., Bowen E. T., Platt G. S., Way H., Simpson D. I. Ebola and Marburg viruses: I. Some ultrastructural differences between strains when grown in Vero cells. J. Med. Virol. 4:1979;201-211.
13. Emond R. T., Evans B., Bowen E. T., Lloyd G. A case of Ebola virus infection. Br. Med. J. 2:1977;541-544.
14. Feldmann H., Bugany H., Mahner F., Klenk H.-D., Drenckhahn D., Schnittler H.-J. Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. J. Virol. 70:1996;2208-2214.
15. Feldmann H., Mühlberger E., Randolf A., Will C., Kiley M. P., Sanchez A., Klenk H. D. Marburg virus, a filovirus: Messenger RNAs, gene order, and regulatory elements of the replication cycle. Virus Res. 24:1992;1-19.
16. Feldmann H., Nichol S. T., Klenk H. D., Peters C. J., Sanchez A. Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology. 199:1994;469-473.
17. Gallaher W. R. Similar structural models of the transmembrane proteins of Ebola and avian sarcoma viruses. Cell. 85:1996;477-478.
18. Garcin D., Pelet T., Calain P., Roux L., Curran J., Kolakofsky D. A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: Generation of a novel copy-back nondefective interfering virus. EMBO J. 14:1995;6087-6094.
19. Geisbert T. W., Jahrling P. B. Differentiation of filoviruses by electron microscopy. Virus Res. 39:1995;129-150.
20. Georges-Courbot M.-C., Sanchez A., Lu C.-Y., Baize S., Leroy E., Lansout-Soukate J., Tevi-Benissan C., Georges A. J., Trappier S. G., Zaki S. R., Swanepoel R., Leman P. A., Rollin P. E., Peters C. J., Nichol S. T., Ksiazek T. G. Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon. Emerg. Infect. Dis. 3:1997;59-62.
21. Hausmann S., Jacques J. P., Kolakofsky D. Paramyxovirus RNA editing and the requirement for hexamer genome length. RNA. 2:1996;1033-1045.
22. Hoffman M. A., Banerjee A. K. An infectious clone of human parainfluenza virus type 3. J. Virol. 71:1997;4272-4277.
23. Holland J., Spindler K., Horodyski F., Grabau E., Nichol S., VandePol S. Rapid evolution of RNA genomes. Science. 215:1982;1577-1585.
24. Kissling R. E., Murphy F. A., Henderson B. E. Marburg virus. Ann. N.Y. Acad. Sci. 174:1970;932-945.
25. Ksiazek T. G., Rollin P. E., Williams A. J., Bressler D. S., Martin M. L., Swanepoel R., Burt F. J., Leman P. A., Khan A. S., Rowe A. K., Mukunu R., Sanchez A., Peters C. J. Isolated cases of Ebola (subtype Reston) virus among quarantined non-human primates recently imported from the Philippines to the United States. J. Infect. Dis. 179:1999;S177-S187.
26. Lawson N. D., Stillman E. A., Whitt M. A., Rose J. K. Recombinant vesicular stomatitis viruses from DNA. Proc. Natl. Acad. Sci. USA. 92:1995;4477-4481.
27. LeGuenno B., Formenty P., Wyers M., Gounon P., Walker F., Boesch C. Isolation and partial characterisation of a new strain of Ebola virus. Lancet. 345:1995;1271-1274.
28. Lu M., Blacklow S. C., Kim P. S. A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nature Struct. Biol. 2:1995;1075-1082.
29. Martini G. A. Marburg agent disease: In man. Trans. R. Soc. Trop. Med. Hyg. 63:1969;295-302.
30. McLaren L. C., Holland J. J. Defective interfering particles from poliovirus vaccine and vaccine reference strains. Virology. 60:1974;579-583.
31. Morzunov S. P., Winton J. R., Nichol S. T. The complete genome structure and phylogenetic relationship of infectious hematopoietic necrosis virus. Virus Res. 38:1995;175-192.
32. Moscona A., Peluso R. W. Persistent infection with human parainfluenza virus 3 in CV-1 cells: Analysis of the role of defective interfering particles. Virology. 194:1993;399-402.
33. Muhlberger E., Lotfering B., Klenk H.-D., Becker S. Three of four nucleocapsid proteins of marburg virus, NP, VP35, and L, are sufficient to mediate replication and transcription of marburg virus-specific monocistronic minigenomes. J. Virol. 72:1998;8756-8764.
34. Muhlberger E., Weik M., Volchkov V. E., Klenk H.-D., Becker S. Comparison of the transcription and replication strategies of Marburg virus and Ebola virus using artificial replication systems. J. Virol. 73:1999;2333-2342.
35. Murphy S. K., Parks G. D. Genome nucleotide lengths that are divisable by six are not essential but enhance replication of defective interfering RNAs of the paramyxovirus simian virus 5. Virology. 232:1997;145-157.
36. Nichol S. T., O'Hara P. J., Holland J. J., Perrault J. Structure and origin of a novel class of defective interfering particle of vesicular stomatitis virus. Nucleic Acids Res. 12:1984;2775-2790.
37. Perrault J. Origin and replication of defective interfering particles. Curr. Top. Microbiol. Immunol. 93:1981;151-207.
38. Radecke F., Spielhofer P., Schneider H., Kaelin K., Huber M., Dotsch C., Christiansen G., Billeter M. A. Rescue of measles viruses from cloned DNA. EMBO J. 14:1995;5773-5784.
39. Re G. G. Deletion mutants of paramyxoviruses. Kinsbury D. W. The Paramyxoviruses. 1991;275-298 Plenum Press, New York, London.
40. Roberts S. R., Lichtenstein D., Ball L. A., Wertz G. W. The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesized from alternative initiation codons. J. Virol. 68:1994;4538-4546.
41. Rodriguez L., De Roo A., Guimard Y., Trappier S., Sanchez A., Bressler D., Williams A. J., Ksiazek T. G., Peters C. J., Nichol S. T. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Zaire 1995. J. Infect. Dis. 179:1999;S170-S176.
42. Rollin P. E., Williams J., Bressler D. S., Pearson S., Cottingham M., Pucak G., Sanchez A., Trappier S. G., Peters R. L., Greer P. W., Zaki S., Demarcus T., Hendricks K., Kelley M., Simpson D., Geisbert T. W., Jahrling P. B., Peters C. J., Ksiazek T. G. Ebola (subtype Reston) virus among quarantined non-human primates recently imported from the Philippines to the United States. J. Infect. Dis. 179:1999;S108-S114.
43. Roux L., Simon A. E., Holland J. J. Effects of defective interfering viruses on virus replication and pathogenesis in vitro and in vivo. Adv. Virus Res. 40:1991;181-211.
44. Samal S. K., Collins P. L. RNA replication by a respiratory syncytial virus RNA analog does not obey the rule of six and retains a nonviral trinucleotide extension at the leader end. J. Virol. 70:1996;5075-5082.
45. Sambrook, J, et al, 1989, Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
46. Sanchez A., Kiley M. P., Holloway B. P., Auperin D. D. Sequence analysis of the Ebola virus genome - Organization genetic elements, and comparison of the genome of Marburg virus. Virus Res. 29:1993;215-240.
47. Sanchez A., Kiley M. P., Holloway B. P., McCormick J. B., Auperin D. D. The nucleoprotein gene of Ebola virus: Cloning, sequencing, and in vitro expression. Virology. 170:1989;81-91.
48. Sanchez A., Trappier S. G., Mahy B. W. J., Peters C. J., Nichol S. T. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc. Natl. Acad. Sci. USA. 93:1996;3602-3607.
49. Schnell M. J., Mebatsion T., Conzelmann K. K. Infectious rabies viruses from cloned cDNA. EMBO J. 13:1994;4195-4203.
50. Segev Y., Ofir R., Salzberg S., Heller A., Weinstein Y., Isakov N., Udem S., Wolfson M., Rager-Zisman B. Tyrosine phosphorylation of measles virus nucleocapsid protein in persistently infected neuroblastoma cells. J. Virol. 69:1995;2480-2485.
51. Sidhu M. S., Chan J., Kaelin K., Spielhofer P., Radecke F., Schneider H., Masurekar M., Dowling P. C., Billeter M. A., Udem S. A. Rescue of synthetic measles virus minireplicons: Measles genomic termini direct efficient expression and propagation of a reporter gene. Virology. 208:1995;800-807.
52. Smith D. H., Johnson B. K., Isaacson M., Swanepoel R., Johnson K. M., Killey M., Bagshawe A., Siongok T., Keruga W. K. Marburg-virus disease in Kenya. Lancet. 1:1982;816-820.
53. Stanners C. P., Francoeur A. M., Lam T. Analysis of VSV mutant with attenuated cytopathogenicity: Mutation in viral function, P, for inhibition of protein synthesis. Cell. 11:1977;273-281.
54. Swanepoel R., Leman P. A., Burt F. J., Zachariades N. A., Braack L. E. O., Ksiazek T. G., Rollin P. E., Zaki S. R., Peters C. J. Experimental inoculation of plants and animals with Ebola virus. Emerg. Infect. Dis. 2:1996;321-325.
55. Van der Groen G., Webb P., Johnson K., Lange J., Linsday H., Eliott L. Growth of Lassa and Ebola viruses in different cell lines. Pattyn S. R. Ebola Virus Haemorrhagic Fever. 1978;255-260 ElsevierNorth-Holland Biomedical Press, Amsterdam.
56. Volchkov V. E., Becker S., Volchkova V. A., Ternovoj V. A., Kotov A. N., Netesov S. V., Klenk H.-D. GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerase. Virology. 214:1995;421-430.
57. Volchkov V. E., Blinov V. M., Netesov S. V. The envelope glycoprotein of Ebola virus contains an immunosuppressive-like domain similar to oncogenic retroviruses. FEBS Lett. 305:1992;181-184.
58. Volchkov V. E., Volchkova V. A., Chepurnov A. A., Blinov V. M., Dolnik O., Netesov S. V., Feldmann H. Characterization of the L gene and 5′-trailer region of Ebola virus. J. Gen. Virol. 80:1999;355-362.
59. Volchkov V., Volchkova V., Eckel C., Klenk H.-D., Bouloy M., LeGuenno B., Feldmann H. Emergence of subtype Zaire Ebola virus in Gabon. Virology. 232:1997;139-144.
60. Whelan S. P., Ball L. A., Barr J. N., Wertz G. T. Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. Proc. Natl. Acad. Sci. USA. 92:1995;8388-8392.
61. Bull. WHO. 56:1978a;247-270.
62. Bull. WHO. 56:1978b;271-293.